Cargando…

RSV: perspectives to strengthen the need for protection in all infants

Respiratory syncytial virus (RSV)—the most common viral cause of bronchiolitis—is a significant cause of serious illness among young children between the ages of 0–5 years and is especially concerning in the first year of life. Globally, RSV is a common cause of childhood acute lower respiratory ill...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro Alonso, Jose Antonio, Bont, Louis J., Bozzola, Elena, Herting, Egbert, Lega, Federico, Mader, Silke, Nunes, Marta C., Ramilo, Octavio, Valiotis, George, Olivier, Catherine Weil, Yates, Ann, Faust, Saul N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529565/ https://www.ncbi.nlm.nih.gov/pubmed/34674730 http://dx.doi.org/10.1186/s12982-021-00104-5

Ejemplares similares

The assessment of future RSV immunizations: How to protect all infants?
por: Bont, Louis, et al.
Publicado: (2022)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

Meeting Report: Harmonization of RSV therapeutics – from design to performance
por: Nair, Harish, et al.
Publicado: (2016)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

89. The Impact of Nirsevimab on an RSV Season in All Infants: Data From The HARMONIE Study
por: Faust, Saul N, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Quantifying the RSV immunity debt following COVID-19: a public health matter
por: Billard, Marie-Noëlle, et al.
Publicado: (2022)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union
por: van Beek, Dianne, et al.
Publicado: (2013)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
por: Esposito, Susanna, et al.
Publicado: (2022)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta–analysis
por: Chan, Markus, et al.
Publicado: (2017)

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
por: Torres, Juan Pablo, et al.
Publicado: (2010)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023)

Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines
por: Prunas, Ottavia, et al.
Publicado: (2023)

1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
por: Brenes-Chacon, Helena, et al.
Publicado: (2020)

A systematic review on global RSV genetic data: Identification of knowledge gaps
por: Langedijk, Annefleur C., et al.
Publicado: (2021)

Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk
por: den Hartog, Gerco, et al.
Publicado: (2014)

Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study
por: Löwensteyn, Yvette N., et al.
Publicado: (2020)

Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study
por: Willemsen, Joukje E., et al.
Publicado: (2023)

International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection
por: Stoppelenburg, Arie Jan, et al.
Publicado: (2013)

Strategies to support HIV literacy in the roll-out of pre-exposure prophylaxis in Scotland: findings from qualitative research with clinical and community practitioners
por: Young, Ingrid, et al.
Publicado: (2020)

External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study
por: Vos, Laura M., et al.
Publicado: (2019)

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study
por: Tabor, David E., et al.
Publicado: (2020)

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months
por: Stuart, Arabella S V, et al.
Publicado: (2022)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
por: Kieffer, Alexia, et al.
Publicado: (2022)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kihjo0fk898l6r61vbs2kl8avb